Skip to main content
SpringerLink
Log in

Adolescent Vaccination Strategies: Interventions to Increase Coverage

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

While vaccines have decreased the burden of disease, many adolescents still remain under-immunized, particularly for human papillomavirus (HPV) and influenza. We review the most current data regarding adolescent immunizations in the United States and discuss proven strategies that work for increasing vaccination rates. Strategies that have been shown to improve rates include provider feedback, immunization information systems (or registries), and enhanced access outside of provider offices, such as school-based immunization programs. Overall, practices may want to consider multimodal quality improvement approaches to enhance practice vaccination rates. The public health and cost benefits of immunizing adolescents are well known, yet recent measles outbreaks in the United States have highlighted issues with state immunization laws and vaccine refusals. Providers should be clear in their advice regarding vaccines and use effective reminder strategies as parents commonly cite not having enough information or knowledge that a vaccine was needed for their adolescent. Additional research is needed regarding adolescent consent for vaccines, as well as adolescent and parental refusal, in order to design systems that will help inform families and allow for widespread vaccine availability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders; 2004. p. 1–15.

    Google Scholar 

  2. Lehmann C, Benson PAS. Vaccine adherence in adolescents. Clin Pediatr. 2009;48:801–11.

    Article  Google Scholar 

  3. Strikas RA, Advisory Committee on Immunization Practices, (ACIP), ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:93–4.

    PubMed  Google Scholar 

  4. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 to 18 years, United States, 2016. http://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Accessed 2 Feb 2016.

  5. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:784–92.

    Article  PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention. Influenza (flu): flu vaccination coverage, United States, 2013–14 influenza season. http://www.cdc.gov/flu/fluvaxview/coverage-1314estimates.htm. Updated 1 Feb 2016. Accessed 15 Jan 2016.

  7. Grohskopf LA, Sokolow LZ, Olsen SJ, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 influenza season. MMWR Morb Mortal Wkly Rep. 2015;64:818–25.

    Article  PubMed  Google Scholar 

  8. Cox NJ, Subbarao K. Influenza. Lancet. 1999;354:1277–82.

    Article  CAS  PubMed  Google Scholar 

  9. American Academy of Pediatrics. Influenza. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 report of the committee on infectious diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 476–93.

    Google Scholar 

  10. Centers for Disease Control and Prevention. Influenza vaccination: a summary for clinicians. http://www.cdc.gov/flu/professionals/vaccination/vax-summary.htm. Accessed 15 Jan 2016.

  11. American Academy of Pediatrics. Pertussis (whooping cough). In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 report of the committee on infectious diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 608–21.

    Google Scholar 

  12. GlaxoSmithKline Biologicals. BOOSTRIX® package insert. https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Boostrix/pdf/BOOSTRIX.PDF. Accessed 15 Jan 2016.

  13. United States Food and Drug Administration. Adacel® package insert. http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm142764.pdf. Accessed 15 Jan 2016.

  14. Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40:187–93.

    Article  PubMed  Google Scholar 

  15. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180:1415–23.

    Article  CAS  PubMed  Google Scholar 

  16. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100B: a review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(pt B):1–441.

  17. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63(RR05):1–30.

    Google Scholar 

  18. Merck. Gardasil® package insert. https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf. Accessed 15 Jan 2016.

  19. American Academy of Pediatrics. Human papillomaviruses. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 report of the committee on infectious diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 576–83.

    Google Scholar 

  20. de Sanjosé S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–56.

    Article  PubMed  Google Scholar 

  21. GlaxoSmithKline Biologicals. Cervarix® package insert. https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Cervarix/pdf/CERVARIX-PI-PIL.PDF. Accessed 15 Jan 2016.

  22. Merck. Gardasil 9® package insert. https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf. Accessed 15 Jan 2016.

  23. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27.

    Article  PubMed  Google Scholar 

  24. Petrosky E, Bocchini JA Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300–4.

    PubMed  Google Scholar 

  25. Centers for Disease Control and Prevention. Meningococcal disease. In: Hamborsky J, Kroger A, Wolfe C, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2015. p. 231–46.

    Google Scholar 

  26. Frasch CE, Tsai CM, Mocca LF. Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease. Clin Invest Med. 1986;9(2):101–7.

    CAS  PubMed  Google Scholar 

  27. American Academy of Pediatrics. Meningococcal infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 report of the committee on infectious diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 547–58.

    Google Scholar 

  28. United States Food and Drug Administration. Menectra® package insert. http://www.fda.gov/downloads/BiologicBloodVaccines/Vaccines/ApprovedProducts/UCM131170.pdf. Accessed 15 Jan 2016.

  29. United States Food and Drug Administration. Menveo® package insert. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM201349.pdf. Accessed 15 Jan 2016.

  30. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62(RR02):1–22.

    Google Scholar 

  31. Shea MW. The long road to an effective vaccine for meningococcus group B (MenB). Ann Med Surg (London). 2013;2(2):53–6.

    Article  Google Scholar 

  32. United States Food and Drug Administration. Trumenba® package insert. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM421139.pdf. Accessed 15 Jan 2016.

  33. United States Food and Drug Administration. Bexsero® package insert. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf. Accessed 15 Jan 2016.

  34. MacNeil JR, Rubin L, Folaranmi T, et al. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(41):1171–6.

    Article  PubMed  Google Scholar 

  35. American Academy of Pediatrics. Rubella. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 report of the committee on infectious diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 688–95.

    Google Scholar 

  36. American Academy of Pediatrics. Varicella-zoster virus infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 report of the committee on infectious diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 846–60.

    Google Scholar 

  37. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:e44–100.

    Article  PubMed  Google Scholar 

  38. Centers for Disease Control and Prevention. Hepatitis A. In: Hamborsky J, Kroger A, Wolfe C, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2015. p. 135–48.

    Google Scholar 

  39. American Academy of Pediatrics. Pneumococcal infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 report of the committee on infectious diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. p. 626–38.

    Google Scholar 

  40. Roush SW, Murphy TV, Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155–63.

    Article  CAS  PubMed  Google Scholar 

  41. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5 suppl):S58–61.

    Article  PubMed  Google Scholar 

  42. Skoff TH, Martin SW. Impact of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccinations on reported pertussis cases among those 11 to 18 years of age in an era of waning pertussis immunity: a follow-up analysis. JAMA Pediatr. 2016. doi:10.1001/jamapediatrics.2015.4875 (Available online 28 Mar).

    PubMed  Google Scholar 

  43. Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. JAMA. 2016;315(11):1149–58.

    Article  PubMed  Google Scholar 

  44. Ortega-Sanchez IR, Lee GM, Jacobs RJ, et al. Projected cost-effectiveness of new vaccines for adolescents in the United States. Pediatrics. 2008;121(suppl 1):S63–78.

    Article  PubMed  Google Scholar 

  45. Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis. 2004;10:1915–23.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Centers for Disease Control and Prevention. Measles cases and outbreaks. http://www.cdc.gov/measles/cases-outbreaks.html. Accessed 15 Jan 2016.

  47. Centers for Disease Control and Prevention. Influenza activity—United States, 2012–13 season and composition of the 2013–14 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2013;62(23):473–9.

    Google Scholar 

  48. Centers for Disease Control and Prevention. CDC reports about 90 percent of children who died from flu this season not vaccinated. http://www.cdc.gov/flu/spotlights/children-flu-deaths.htm. Accessed 15 Jan 2016.

  49. Community Preventive Services Task Force. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18:92–6.

    Article  Google Scholar 

  50. Increasing appropriate vaccination. Community Preventive Services Task Force (CPSTF) website. http://www.thecommunityguide.org/vaccines/index.html. Updated 23 Dec 2015. Accessed 14 Apr 2016.

  51. Centers for Disease Control and Prevention. AFIX (Assessment, Feedback, Incentives, and eXchange). http://www.cdc.gov/vaccines/programs/afix/index.html. Updated 15 Apr 2015. Accessed 16 Dec 2015.

  52. Dietz VJ, Baughman AL, Dini EF, et al. Vaccination practices, policies, and management factors associated with high vaccination coverage levels in Georgia public clinics. Arch Pediatr Adolesc Med. 2000;154(2):184–9.

    Article  CAS  PubMed  Google Scholar 

  53. Centers for Disease Control and Prevention. Immunization strategies for healthcare practices and providers: The need for strategies to increase immunization levels. In: Hamborsky J, Kroger A, Wolfe C, editors. Epidemiology and prevention of the vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2015. p. 39.

  54. Centers for Disease Control and Prevention. Vaccines and immunizations: quality improvement projects targeting immunization. http://www.cdc.gov/vaccines/ed/quality-improvement-proj.htm. Updated 23 Apr 015. Accessed 16 Dec 2015.

  55. Almquist J. Survey details pediatricians’ knowledge, use of immunization registries. AAP News. 2013;35:33. http://www.aappublications.org/content/35/1/33.short.

  56. Centers for Disease Control and Prevention. Current status: continued operations of the NCIRD IIS strategic plan. April 2015 update. http://www.cdc.gov/vaccines/programs/iis/downloads/strategic-update-2015-04.pdf. Accessed 16 Dec 2015.

  57. Stokley S, Coh A, Jain N, McCauley MM. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years. Arch Pediatr Adolesc Med. 2011;165:813–8.

    Article  PubMed  Google Scholar 

  58. Greenfield LS, Page LC, Kay M, et al. Strategies for increasing adolescent immunizations in diverse ethnic communities. J Adolesc Health. 2015;56(5 suppl):S47–53.

    Article  PubMed  Google Scholar 

  59. Stockwell MS, Kharbanda EO, Martinez RA, et al. Text4Health: impact of text message reminder–recalls for pediatric and adolescent immunizations. Am J Public Health. 2012;102:e15–21.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care. 2014;28:e35–9.

    Article  PubMed  Google Scholar 

  61. Morris J, Wang W, Wang L, et al. Comparison of reminder methods in selected adolescents with records in an immunization registry. J Adolesc Health. 2015;56:S27–32.

    Article  PubMed  Google Scholar 

  62. McKibben LJ, Stange PV, Sneller VP, et al. Use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2000;49(RR-1):15–6.

  63. Nowalk MP, Nutini J, Raymund M, Ahmed F, Albert SM, Zimmerman RK. Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: a multimodal pilot project. Vaccine. 2012;30:5978–82.

    Article  PubMed  Google Scholar 

  64. Kahn JA, Rickert VI. Innovative clinical and public health strategies to promote adolescent vaccination. J Adolesc Health. 2015;56:S1–2.

    Article  PubMed  Google Scholar 

  65. Demsey AF, Freed GL. Health care utilization by adolescents on Medicaid: implications for delivering vaccines. Pediatrics. 2012;125:43–9.

    Article  Google Scholar 

  66. Lee GM, Lorick SA, Pfoh E, Kleinman K, Fishbein D. Adolescent immunizations: missed opportunities for prevention. Pediatrics. 2008;122:711–7.

    Article  PubMed  Google Scholar 

  67. Fiks AG, Hunter KF, Localio AR, Grundmeier RW, Alessandrini EA. Impact of immunization at sick visits on well-child care. Pediatrics. 2008;121:898–905.

    Article  PubMed  Google Scholar 

  68. Community Preventive Services Task Force. Recommendation for use of immunization information systems to increase vaccination rates. J Public Health Manag Pract. 2015;21:249–52.

    Article  Google Scholar 

  69. Daley MF, Curtis CR, Pyrzanowski J, et al. Adolescent immunization delivery in school-based health centers: a national survey. J Adolesc Health. 2009;45:445–52.

    Article  PubMed  Google Scholar 

  70. Gargano LM, Weiss P, Undewood NL, et al. School-located vaccination clinics for adolescents: correlates of acceptance among parents. J Commun Health. 2015;40:660–9.

    Article  Google Scholar 

  71. Middleman AB, Tung JS. School-located immunization programs: do parental preferences predict behavior? Vaccine. 2011;29:3513–6.

    Article  PubMed  Google Scholar 

  72. Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014;13:235–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Lau JS, Adams SH, Park J, Boscardin J, Irwin CE Jr. Improvement in preventive care of young adults after the Affordable Care Act: the Affordable Care Act is helping. JAMA Pediatr. 2014;168:1101–6.

    Article  PubMed  Google Scholar 

  74. Gowda C, Dempsey AF. Medicaid reimbursement and the uptake of adolescent vaccines. Vaccine. 2012;30:1682–9.

    Article  PubMed  Google Scholar 

  75. O’Leary ST, Allison MA, Lindley MC, et al. Vaccine financing from the perspective of primary care physicians. Pediatrics. 2014;133:367–74.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Society for Adolescent Health and Medicine. Financing vaccines for adolescents: a position paper of the Society for Adolescent Health and Medicine. J Adolesc Health. 2011;48:320–1.

    Article  Google Scholar 

  77. Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011;165:547–53.

    Article  PubMed  Google Scholar 

  78. Mazzoni SE, Brewer SE, Pyrzanowski JL, et al. Effect of a multi-modal intervention on immunization rates in obstetrics and gynecology clinics. Am J Obstet Gynecol. 2015. doi:10.1016/j.ajog.2015.11.018 (Available online 25 Nov 2015).

    PubMed  Google Scholar 

  79. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med. 2009;360:1981–8.

    Article  CAS  PubMed  Google Scholar 

  80. Orenstein WA, Hinman AR. The immunization system in the United States—the role of school immunization laws. Vaccine. 1999;17:S19–24.

    Article  PubMed  Google Scholar 

  81. Averhoff F, Linton L, Peddecord KM, Edwards C, Wang W, Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health. 2004;94:978–84.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Wang E, Clymer J, Davis-Hayes C, Buttenheim A. Nonmedical exemptions from school immunization requirements: a systematic review. Am J Public Health. 2014;104:e62–84.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Mello MM, Studdert DM, Parmet WE. Shifting vaccination politics—the end of personal-belief exemptions in California. N Engl J Med. 2015;373:785–7.

    Article  PubMed  Google Scholar 

  84. Majumder MS, Cohn EL, Mekaru SR, Huston JE, Brownstein JS. Substandard vaccination compliance and the 2015 measles outbreak. JAMA Pediatr. 2015;169:494–5.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Baughman AL, Williams WW, Atkinson WL, Cook LG, Collins M. The impact of college prematriculation immunization requirements on risk for measles outbreaks. JAMA. 1994;272(14):1127–32.

    Article  CAS  PubMed  Google Scholar 

  86. Office for State, Tribal, Local and Territorial Support, Centers for Disease Control and Prevention. State school immunization requirements and vaccine exemption laws. http://www.cdc.gov/phlp/docs/school-vaccinations.pdf. 27 Mar 2015. Accessed 16 Dec 2015.

  87. Immunization Action Coalition. State mandates on immunization and vaccine-preventable diseases. http://www.immunize.org/laws. Updated 16 Oct 2015. Accessed 16 Dec 2015.

  88. Gilkey MB, McRee A-L, Brewer NT. Forgone vaccination during childhood and adolescence: findings of a statewide survey of parents. Prev Med. 2013;56:202–6.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Dorell C, Yankey D, Jeyarajah S, et al. Delay and refusal of human papillomavirus vaccine for girls, national immunization survey-teen, 2010. Clin Pediatr (Phila). 2014;53:261–9.

    Article  PubMed  Google Scholar 

  90. Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine. 2012;30:4807–12.

    Article  PubMed  Google Scholar 

  91. Ford CA, Skiles MP, English A, et al. Minor consent and delivery of adolescent vaccines. J Adolesc Health. 2014;54:183–9.

    Article  PubMed  Google Scholar 

  92. English A, Ford CA, Kahn JA, Kharbanda EO, Middleman AB. Adolescent consent for vaccination: a position paper of the Society for Adolescent Health and Medicine. J Adolesc Health. 2013;53:550–3.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge Jan Clavey, B.A., for her assistance in preparing this manuscript.

Author information

Authors and Affiliations

  1. Division of Adolescent and Transition Medicine, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 4000, Cincinnati, OH, 45229, USA

    Corinne E. Lehmann & Reuben O. Battley

  2. Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 6014, Cincinnati, OH, 45229, USA

    Rebecca C. Brady

  3. Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 4010, Cincinnati, OH, 45229, USA

    Jennifer L. Huggins

Authors
  1. Corinne E. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca C. Brady
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reuben O. Battley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer L. Huggins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Corinne E. Lehmann.

Ethics declarations

Drs Lehman, Brady, and Huggins have disclosed that they receive research grant funding from Pfizer. They do not have a financial conflict of interest related to this article. Dr. Battley has no conflicts of interest. This article does not contain a discussion of an unapproved/investigative use of a commercial product or device. No sources of funding were used to support the writing of this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lehmann, C.E., Brady, R.C., Battley, R.O. et al. Adolescent Vaccination Strategies: Interventions to Increase Coverage. Pediatr Drugs 18, 273–285 (2016). https://doi.org/10.1007/s40272-016-0177-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40272-016-0177-1

Keywords

Search

Navigation